Arax Advisory Partners’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
Other funds holding MRVI
1WCM
Arax Advisory Partners's MRVI Position: Q3 2026 in Review
Arax Advisory Partners increased its Maravai LifeSciences (MRVI) stake by 17% in Q3 2026, buying an estimated $1.42K and bringing the position to 1,380 shares worth $10.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4385.
Arax Advisory Partners first reported a position in MRVI in Q2 2021 and has held it in 14 quarters since. The position peaked at $46.3K in Q3 2024. 202 funds tracked by Wall St. Rank hold MRVI as of Q3 2026.
- Arax Advisory Partners held 1,380 shares of Maravai LifeSciences worth $10.6K as of Q3 2026.
- Arax Advisory Partners bought 205 Maravai LifeSciences shares in Q3 2026, an estimated $1.42K.
- Maravai LifeSciences made up ﹤0.01% of Arax Advisory Partners's portfolio in Q3 2026, its #4385 holding.
- Arax Advisory Partners first reported a position in Maravai LifeSciences in Q2 2021 and has held it in 14 quarters since.
- Arax Advisory Partners's Maravai LifeSciences position peaked at $46.3K in Q3 2024.
- 202 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2026.
Based on Arax Advisory Partners's 13F filing for Q3 2026, filed 12 Nov 2026.